EUROFINS BIOPHARMA PRODUCT TESTING NORWAY AS

931468065AksjeselskapMVA
Municipality
MOSS
Founded
20.07.2023
Roles
4
Company details
Business address
Møllebakken 40, 1538 MOSS
Municipality
Moss
Sector
Private aksjeselskaper mv.
Share capital
30 000 kr(30 000 shares)
Registered
07.09.2023
Purpose
Å tilby GxP laboratorie- og hertil relaterede ytelser til farmasøytiske, biofarmasøytiske og medisinsk utstyr sektorene i overensstemmelse med globalt gjeldende GxP regler og regulerende helsemyndigheters krav og forventinger.
Board and management

Styre og ledelse

Daglig leder
Styremedlem
Styrets leder

Revisor

CEDRA NORGE AS

Is revisor for 7 115 companies

Revisor

Relationship graph

Explore in 3D
Loading graph...
Click a node to navigate. Drag to move. Company PersonStyreDaglig lederRevisorRegnskapInnehaverOpen in 3D →
Financials2024
Revenue
1.2 mill
Operating result
452k
Net result
348k
Assets
1.3 mill
Equity
696k
Debt
646k
Financial health check
Equity ratio
Very good
Current ratio
Very good
Profitability
Very good
Income statement and balance sheet
2024
Income statement
Revenue1.2 mill
Operating costs773k
= Operating result452k
Net finance-5k
= Net result348k
Balance sheet
Fixed assets0
Current assets1.3 mill
= Total assets1.3 mill
Equity696k
Long-term debt0
Short-term debt646k
= Total debt646k

Source: Brønnøysund Register Centre

Key Ratios
2024Industry (median)
Operating margin
36.9%-3.7%
Net margin
28.4%
Return on assets
33.3%-0.2%
Return on equity
50.1%
Equity ratio
51.8%50.7%
Current ratio
2.081.90
Debt-to-equity
0.930.62

Based on 648 companies

Source: Brønnøysund Register Centre. Ratios are calculated using universal formulas.

Previous roles

Powered by Webagent — digital solutions for Norwegian businesses

Powered by Webagent